These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

39 related items for PubMed ID: 21064030

  • 1. Cervical nitric oxide release and persistence of high-risk human papillomavirus in women.
    Rahkola P, Väisänen-Tommiska M, Tuomikoski P, Ylikorkala O, Mikkola TS.
    Int J Cancer; 2011 Jun 15; 128(12):2933-7. PubMed ID: 21064030
    [Abstract] [Full Text] [Related]

  • 2. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
    Sammarco ML, Del Riccio I, Tamburro M, Grasso GM, Ripabelli G.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun 15; 168(2):222-6. PubMed ID: 23395560
    [Abstract] [Full Text] [Related]

  • 3. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
    Wei XM, Wang Q, Gao SJ, Sui L.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Apr 15; 46(4):260-5. PubMed ID: 21609578
    [Abstract] [Full Text] [Related]

  • 4. Cervical nitric oxide release in Chlamydia trachomatis and high-risk human papillomavirus infection.
    Rahkola P, Väisänen-Tommiska M, Hiltunen-Back E, Auvinen E, Ylikorkala O, Mikkola TS.
    Acta Obstet Gynecol Scand; 2011 Sep 15; 90(9):961-5. PubMed ID: 21644935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased release of cervical nitric oxide in spontaneous abortion before clinical symptoms: a possible mechanism for preabortal cervical ripening.
    Väisänen-Tommiska M, Mikkola TS, Ylikorkala O.
    J Clin Endocrinol Metab; 2004 Nov 15; 89(11):5622-6. PubMed ID: 15531520
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology.
    Carcopino X, Bolger N, Henry M, Mancini J, Boubli L, Olive D, Cleary S, Prendiville W, Tamalet C.
    J Med Virol; 2011 Apr 15; 83(4):637-43. PubMed ID: 21328378
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: significance of newly detected hr-HPV genotypes.
    van Ham MA, van Hamont D, Bekkers RL, Bulten J, Melchers WJ, Massuger LF.
    J Med Virol; 2007 Mar 15; 79(3):314-9. PubMed ID: 17245729
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.
    Cytopathology; 2009 Aug 15; 20(4):249-55. PubMed ID: 19018810
    [Abstract] [Full Text] [Related]

  • 12. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
    Gold MA, Thomas MA, Huh WK, Sarto GE, Day SP.
    J Low Genit Tract Dis; 2013 Jan 15; 17(1):51-7. PubMed ID: 22885641
    [Abstract] [Full Text] [Related]

  • 13. Involvement of the Toll-Like Receptor/Nitric Oxide Signaling Pathway in the Pathogenesis of Cervical Cancer Caused by High-Risk Human Papillomavirus Infection.
    Li J, Rao H, Jin C, Liu J.
    Biomed Res Int; 2017 Jan 15; 2017():7830262. PubMed ID: 28626766
    [Abstract] [Full Text] [Related]

  • 14. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V, Poljak M, Oštrbenk A, Klavs I.
    J Med Virol; 2014 Oct 15; 86(10):1772-9. PubMed ID: 24978445
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide metabolites in cervical fluid during pregnancy: further evidence for the role of cervical nitric oxide in cervical ripening.
    Väisänen-Tommiska M, Nuutila M, Aittomäki K, Hiilesmaa V, Ylikorkala O.
    Am J Obstet Gynecol; 2003 Mar 15; 188(3):779-85. PubMed ID: 12634657
    [Abstract] [Full Text] [Related]

  • 16. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
    Louvanto K, Rautava J, Syrjänen K, Grénman S, Syrjänen S.
    Clin Microbiol Infect; 2014 Nov 15; 20(11):1167-72. PubMed ID: 24890849
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral.
    Moy LM, Zhao FH, Li LY, Ma JF, Zhang QM, Chen F, Song Y, Hu SY, Balasubramanian A, Pan QJ, Koutsky L, Zhang WH, Lim JM, Qiao YL, Sellors JW.
    Int J Cancer; 2010 Aug 01; 127(3):646-56. PubMed ID: 19960441
    [Abstract] [Full Text] [Related]

  • 19. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
    Tabrizi SN, Brotherton JM, Stevens MP, Condon JR, McIntyre P, Smith D, Garland SM, WHINURS group.
    J Clin Virol; 2014 Jul 01; 60(3):250-6. PubMed ID: 24854516
    [Abstract] [Full Text] [Related]

  • 20. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
    Kwan TT, Cheung AN, Lo SS, Lee PW, Tam KF, Chan KK, Ngan HY.
    Acta Obstet Gynecol Scand; 2011 May 01; 90(5):445-51. PubMed ID: 21306349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.